Jose Maria M. T.
- Country
- Spain
- Department
- Unidad Investigación Translacional (UIT).
Research Overview
- A Randomized Controlled Trial Comparing the Efficacy of Umeclidinium Bromide, Fluticasone Furoate, and Vilanterol Versus LABA-LAMA Combination in High-Risk COPD Patients
- Non-Inferiority Trial of Depemokimab Versus Mepolizumab or Benralizumab in Severe Eosinophilic Asthma Patients
- Long-term Safety Evaluation of Depemokimab in Adults and Adolescents with Severe Eosinophilic Asthma: An Open-Label Extension Study
Data & Insights
Has run more than one trial at 80 of 361 partner sites.
Specializations
Respiratory Disease Management
This investigator specializes in treating complex respiratory conditions, with particular emphasis on Chronic Obstructive Pulmonary Disease (COPD) and its various manifestations including chronic bronchitis. Their research focuses on evaluating innovative therapeutic approaches for moderate to severe COPD patients.
- COPD Exacerbation Management
- Triple Therapy Optimization
- Long-term Disease Control
Asthma Treatment Innovation
The investigator demonstrates significant expertise in treating severe asthma, particularly focusing on patients with eosinophilic phenotype. Their work includes evaluation of novel biological therapies and maintenance treatments for uncontrolled asthma.
- Biological Therapy Assessment
- ICS-containing Background Therapy
- Asthma Exacerbation Prevention
Advanced Therapeutic Applications
Research interests extend to investigating novel therapeutic compounds and their applications in respiratory medicine. The investigator explores long-term safety profiles and clinical efficacy of experimental treatments in both COPD and asthma contexts.
- Biomarker Assessment
- Safety Profile Evaluation
- Treatment Tolerability Studies
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.